Pranshu Suri is an Analyst at Catalio Capital Management, LP focusing on public equity investments across healthcare with a specialization in biotech.
Prior to joining Catalio, Pranshu was an Investment Banking Analyst in the Global Healthcare Group at Morgan Stanley.
Pranshu graduated from the Jerome Fisher Program in Management and Technology (M&T) at the University of Pennsylvania, earning a B.S. in Economics from Wharton with a concentration in Finance, as well as a B.S. in Bioengineering from the School of Engineering and Applied Science.